Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Greer Website

Yoshimi Endo Greer, M.D., Ph.D.

Selected Publications

1)  Greer YE, Westlake CJ, Gao B, Bharti K, Shiba Y, Xavier CP, Pazour GJ, Yang Y, Rubin JS.
Casein Kinase 1 Delta Functions at the Centrosome and Golgi to Promote Ciliogenesis.
Mol. Biol. Cell. [Epub ahead of print], 2014.
[Journal]
2)  Greer YE, Fields AP, Brown AM, Rubin JS.
Atypical Protein Kinase C Iota is Required for Wnt3a-Dependent Neurite Outgrowth and Binds to Phosphorylated Dishevelled2.
J. Biol. Chem. 288: 9438-46, 2013.
[Journal]
3)  Gonzalez-Sancho JM, Greer YE, Abrahams CL, Takigawa Y, Baljinnyam B, Lee KH, Lee KS, Rubin JS, Brown AM.
Functional Consequences of Wnt-Induced Dishevelled2 Phosphorylation in Canonical and Non-Canonical Wnt Signaling.
J. Biol. Chem. 288: 9428-37, 2013.
[Journal]
4)  Nagaoka T, Karasawa H, Turbyville T, Rangel M, Castro NP, Gonzales M, Baker A, Seno M, Lockett S, Greer YE, Rubin JS, Salomon DS, Bianco C.
Cripto-1 enhances the canonical Wnt/beta-catenin signaling pathway by binding to LRP5 and LRP6 co-receptors.
Cell Signal. 25: 178-89, 2012.
[Journal]
5)  Aprelikova O, Palla J, Hibler B, Yu X, Greer YE, Yi M, Stephens R, Maxwell GL, Jazaeri A, Risinger JI, Rubin JS, Niederhuber J.
Silencing of miR-148a in cancer-associated fibroblasts results in WNT10B-mediated stimulation of tumor cell motility.
Oncogene. 32: 3246-53, 2012.
[Journal]
6)  Greer YE, Rubin JS.
Casein kinase 1 delta functions at the centrosome to mediate Wnt-3a-dependent neurite outgrowth.
J. Cell Biol. 192: 993-1004, 2011.
[Journal]
7)  Klauzinska M, Baljinnyam B, Raafat A, Rodriguez-Canales J, Strizzi L, Greer YE, Rubin JS, Callahan R.
Rspo2/Int7 regulates invasiveness and tumorigenic properties of mammary epithelial cells.
J Cell Physiol. 227: 1960-71, 2011.
[Journal]
8)  Greer YE, Rubin JS.
The role of centrosomal casein kinase 1 delta in neurite outgrowth and beyond.
Cell Cycle. 10: 2605-6, 2011.
[Journal]
9)  Beauchamp E, Bulut G, Abaan O, Chen K, Merchant A, Matsui W, Endo Y, Rubin JS, Toretsky J, Uren A.
GLI1 is a direct transcriptional target of EWS-FLI1 oncoprotein.
J. Biol. Chem. 284: 9074-82, 2009.
[Journal]
10)  Li SJ, Yen TY, Endo Y, Klauzinska M, Baljinnyam B, Macher B, Callahan R, Rubin JS.
Loss-of-function point mutations and two-furin domain derivatives provide insights about R-spondin2 structure and function.
Cell. Signal. 21: 916-25, 2009.
[Journal]
11)  Wolf V, Endo Y, Rubin JS.
Purification and Wnt-inhibitory activities of secreted frizzled-related proteins.
Methods Mol. Biol. 468: 31-44, 2008.
[Journal]
12)  Endo Y, Deonauth K, Prahalad P, Hoxter B, Zhu Y, Byers SW.
Role of Sox-9, ER81 and VE-cadherin in retinoic acid-mediated trans-differentiation of breast cancer cells.
PLoS ONE. 3: e2714, 2008.
[Journal]
13)  Endo Y, Beauchamp E, Woods D, Taylor WG, Toretsky JA, Uren A, Rubin JS.
Wnt-3a and Dickkopf-1 stimulate neurite outgrowth in Ewing tumor cells via a Frizzled3- and c-Jun N-terminal kinase-dependent mechanism.
Mol. Cell. Biol. 28: 2368-79, 2008.
[Journal]
14)  Endo Y, Rubin JS.
Wnt signaling and neurite outgrowth: insights and questions.
Cancer Sci. 98: 1311-7, 2007.
[Journal]
15)  Endo Y, Wolf V, Muraiso K, Kamijo K, Soon L, Uren A, Barshishat-Küpper M, Rubin JS.
Wnt-3a-dependent cell motility involves RhoA activation and is specifically regulated by dishevelled-2.
J. Biol. Chem. 280: 777-86, 2005.
[Journal]
16)  Qiang YW, Endo Y, Rubin JS, Rudikoff S.
Wnt signaling in B-cell neoplasia.
Oncogene. 22: 1536-45, 2003.
[Journal]
17)  Yang T, Forrest SJ, Stine N, Endo Y, Pasumarthy A, Castrop H, Aller S, Forrest JN, Schnermann J, Briggs J.
Cyclooxygenase cloning in dogfish shark, Squalus acanthias, and its role in rectal gland Cl secretion.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 283: R631-7, 2002.
[Journal]
18)  Kohagura K, Arima S, Endo Y, Chiba Y, Ito O, Abe M, Omata K, Ito S.
Involvement of cytochrome P450 metabolites in the vascular action of angiotensin II on the afferent arterioles.
Hypertens. Res. 24: 551-7, 2001.
[Journal]
19)  Kohagura K, Endo Y, Ito O, Arima S, Omata K, Ito S.
Endogenous nitric oxide and epoxyeicosatrienoic acids modulate angiotensin II-induced constriction in the rabbit afferent arteriole.
Acta Physiol. Scand. 168: 107-12, 2000.
[Journal]
20)  Yang T, Endo Y, Huang YG, Smart A, Briggs JP, Schnermann J.
Renin expression in COX-2-knockout mice on normal or low-salt diets.
Am. J. Physiol. Renal Physiol. 279: F819-25, 2000.
[Journal]
21)  Yaoita H, Ito O, Arima S, Endo Y, Takeuchi K, Omata K, Ito S.
[Effect of adenosine on isolated afferent arterioles].
Nippon Jinzo Gakkai Shi. 41: 697-703, 1999.
[Journal]
22)  Omata K, Saito T, Sato H, Sato T, Abe F, Yamada M, Yaoita H, Endo Y, Ito S, Kanazawa M, Abe K.
Therapeutic advantage of angiotensin converting enzyme inhibitors in chronic glomerulonephritis.
Immunopharmacology. 44: 43-8, 1999.
[Journal]
23)  Endo Y, Arima S, Yaoita H, Tsunoda K, Omata K, Ito S.
Vasodilation mediated by angiotensin II type 2 receptor is impaired in afferent arterioles of young spontaneously hypertensive rats.
J. Vasc. Res. 35: 421-7, 1998.
[Journal]
24)  Endo Y, Arima S, Yaoita H, Omata K, Tsunoda K, Takeuchi K, Abe K, Ito S.
Function of angiotensin II type 2 receptor in the postglomerular efferent arteriole.
Kidney Int. Suppl. 63: S205-7, 1997.
[Journal]
25)  Arima S, Endo Y, Yaoita H, Omata K, Ogawa S, Tsunoda K, Abe M, Takeuchi K, Abe K, Ito S.
Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole.
J. Clin. Invest. 100: 2816-23, 1997.
[Journal]
Click Here to View Collapsed Bibliography.

This page was last updated on 4/9/2014.